The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 02, 2017
Filed:
Dec. 07, 2012
Applicants:
Centre National DE LA Recherche Scientifique, Paris, FR;
Universite Paris-sud Xi, Orsay, FR;
Institut Gustave Roussy, Villejuif, FR;
Viroxis S.a.s., Paris, FR;
Inventor:
Thierry Heidmann, Paris, FR;
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
UNIVERSITE PARIS-SUD XI, Orsay, FR;
INSITUT GUSTAVE ROUSSY, Villejuif, FR;
VIROXIS S.A.S., Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); C07K 14/16 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/005 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/162 (2013.01); C12N 2740/15022 (2013.01); C12N 2740/15033 (2013.01); C12N 2740/15034 (2013.01); C12N 2740/16022 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16111 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16134 (2013.01);
Abstract
A pharmaceutical composition includes, as active substance a mutated lentiviral ENV protein, substantially devoid of immunosuppressive properties or a variant of the mutated lentiviral ENV protein or a fragment of the above proteins, in association with a pharmaceutically acceptable carrier.